GIANT PAPILLARY CONJUNCTIVITIS

This adverse event was reported 50 times

These drugs are most commonly taken by patients reporting GIANT PAPILLARY CONJUNCTIVITIS:

# Drug Count
0 DUPILUMAB 9
1 LOTEPREDNOL ETABONATE 7
2 BRIMONIDINE TARTRATE 5
3 FLUOROMETHOLONE 4
4 CETIRIZINE HYDROCHLORIDE 3
5 OLOPATADINE 3
6 TOBRAMYCIN 3
7 TOBRAMYCIN SOLUTION 3
8 TOBRAMYCIN SULFATE 3
9 ADALIMUMAB 2
See all common drugs associated with GIANT PAPILLARY CONJUNCTIVITIS

GIANT PAPILLARY CONJUNCTIVITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15% 1 0.0096
1 BENZETHONIUM CHLORIDE 1 0.0078
2 NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE 2 0.0018
3 LOTEPREDNOL ETABONATE 7 0.0013
4 FLUOROMETHOLONE 4 0.0012
5 ALCAFTADINE 1 0.0011
6 OXYMETAZOLINE HYDROCHLORIDE OPHTHALMIC 2 0.0008
7 ARTIFICIAL TEARS 2 0.0008
8 POLYVINYL ALCOHOL, POVIDONE 2 0.0008
9 BROMFENAC SODIUM 1 0.0007
See all drugs enriched for association with GIANT PAPILLARY CONJUNCTIVITIS